|
|
Other links at Articles > Business of Medicine |
| 1. |
More Action Possible Erythropoiesis-Stimulating Agents: US FDA
|
|
|
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with erythropoiesis-stimulating agents, also known as ESAs or Epo drugs, for anemia. Reuters Health Information
|
| 5. |
Aetna, Lawmakers Debate Health Costs, Uninsured
|
|
|
The chief executive of Aetna Inc, one of the biggest U.S. health insurers, on Tuesday told lawmakers the escalating cost of insurance is driven by factors other than excess profits at insurers. Reuters Health Information
|
|
|